Inhibition of NADPH oxidase-1 preserves beta cell function (Q45004022)

8 December 2017

title

Inhibition of NADPH oxidase-1 preserves beta cell function (English)

1 reference

8 December 2017

author

David A Taylor-Fishwick

series ordinal

1 reference

8 December 2017

Jessica R Weaver

1 reference

8 December 2017

Wojciech Grzesik

series ordinal

1 reference

8 December 2017

publication date

3 October 2014

1 reference

8 December 2017

1 reference

8 December 2017

1 reference

8 December 2017

1 reference

8 December 2017

page(s)

113-121

1 reference

CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Oxidative stress: the vulnerable beta-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Pancreatic beta-cells express phagocyte-like NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

L-Alanine induces changes in metabolic and signal transduction gene expression in a clonal rat pancreatic beta-cell line and protects from pro-inflammatory cytokine-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Expression of isoforms of NADPH oxidase components in rat pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Effects of pharmacological inhibition of NADPH oxidase or iNOS on pro-inflammatory cytokine, palmitic acid or H2O2-induced mouse islet or clonal pancreatic β-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

The endoplasmic reticulum stress response in the pancreatic β-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Insights into the critical role of NADPH oxidase(s) in the normal and dysregulated pancreatic beta cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Expression of NADPH oxidase in human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Association of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic beta-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Circulating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Regulation of NOX-1 expression in beta cells: a positive feedback loop involving the Src-kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Inflammatory mechanisms in the regulation of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Decreased blood pressure in NOX1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

TLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Increased Nox1 and hydrogen peroxide in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

NADPH oxidase NOX1 controls autocrine growth of liver tumor cells through up-regulation of the epidermal growth factor receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3398-2

Pro-inflammatory cytokines in Omani type 2 diabetic patients presenting anxiety and depression

21 January 2018

1 reference

12 December 2020

Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement

1 reference

12 December 2020

Differential susceptibility of chick and mouse islets to streptozotocin and its co-relation with islet antioxidant status

1 reference

12 December 2020

Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice

1 reference

12 December 2020

Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat

1 reference

12 December 2020

NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction

1 reference

12 December 2020

10.1007/S00125-014-3398-2

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1032257895

0 references

1 reference